Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Demant Sales Strategic Accounts A/S
A/S
Active
CVR 40974024
Kongebakken 9, 2765
Smørum
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2019
— employees
Watchlist
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Demant Sales Strategic Accounts A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SC
Søren Colding
Chief Executive Officer
Chief Executive Officer
2020
Former (1)
PK
Pelle Kristoffer Munk-Poulsen
Chief Executive Officer
Chief Executive Officer
2019 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
SN
Søren Nielsen
Chairman
2019
RS
René Schneider
Board of Directors
2019
SB
Stine Brandenhof Rifsdal
Board of Directors
2023
Former (1)
PB
Peter Bo Soelberg
Board of Directors
2020 – 2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Demant A/S
Company
100%
100%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Demant Sales Strategic Accounts A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network